Deutsche Bank AG Cuts Stock Holdings in Aspen Aerogels, Inc. $ASPN

Key Points

• Deutsche Bank AG has reduced its stake in Aspen Aerogels by 37.5%, now holding approximately 0.32% of the company, valued at $1.66 million.
• Aspen Aerogels posted a quarterly revenue of $78.02 million, exceeding expectations, but reported a negative net margin of 78.53% and an EPS of ($0.04), beating estimates.
• Analysts have mixed ratings for Aspen Aerogels, with a consensus price target of $19.50, reflecting a range from "Strong Buy" to "Sell" ratings.

Deutsche Bank AG decreased its holdings in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 37.5% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 259,553 shares of the construction company's stock after selling 155,838 shares during the period. Deutsche Bank AG owned about 0.32% of Aspen Aerogels worth $1,659,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Millennium Management LLC lifted its holdings in Aspen Aerogels by 4,757.8% during the 4th quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company's stock valued at $19,270,000 after purchasing an additional 1,588,632 shares during the last quarter. Point72 Asset Management L.P. bought a new position in shares of Aspen Aerogels in the fourth quarter valued at about $13,122,000. Alyeska Investment Group L.P. acquired a new stake in shares of Aspen Aerogels during the 4th quarter worth about $9,504,000. Two Sigma Investments LP boosted its holdings in shares of Aspen Aerogels by 637.9% during the 4th quarter. Two Sigma Investments LP now owns 592,765 shares of the construction company's stock worth $7,042,000 after buying an additional 512,439 shares during the period. Finally, New York State Common Retirement Fund grew its stake in Aspen Aerogels by 2,073.6% in the 1st quarter. New York State Common Retirement Fund now owns 437,572 shares of the construction company's stock valued at $2,796,000 after buying an additional 417,441 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

ASPN has been the topic of several recent research reports. Barclays cut shares of Aspen Aerogels from an "equal weight" rating to an "underweight" rating and raised their target price for the stock from $7.00 to $16.00 in a report on Monday, August 11th. Oppenheimer lowered Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research report on Thursday, May 8th. Finally, Canaccord Genuity Group lowered their price target on shares of Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Aspen Aerogels currently has a consensus rating of "Moderate Buy" and a consensus price target of $19.50.

Insider Transactions at Aspen Aerogels

In other Aspen Aerogels news, CAO Santhosh P. Daniel sold 4,410 shares of the firm's stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total value of $32,237.10. Following the completion of the transaction, the chief accounting officer directly owned 19,879 shares of the company's stock, valued at $145,315.49. This trade represents a 18.16% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 3.40% of the stock is owned by corporate insiders.

Aspen Aerogels Stock Performance

Shares of NYSE:ASPN traded down $0.08 during midday trading on Monday, reaching $6.93. The company had a trading volume of 907,889 shares, compared to its average volume of 2,800,467. The company has a current ratio of 3.98, a quick ratio of 3.31 and a debt-to-equity ratio of 0.34. The stock has a market cap of $570.75 million, a P/E ratio of 43.81 and a beta of 2.73. The company's 50 day moving average price is $6.93 and its 200 day moving average price is $6.69. Aspen Aerogels, Inc. has a 52-week low of $4.16 and a 52-week high of $32.31.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The construction company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.08. The company had revenue of $78.02 million for the quarter, compared to analyst estimates of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The company's quarterly revenue was down 33.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.21 earnings per share. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. As a group, sell-side analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.